Natural language processing in clinical neuroscience and psychiatry: A review

C Crema, G Attardi, D Sartiano, A Redolfi - Frontiers in Psychiatry, 2022 - frontiersin.org
Natural language processing (NLP) is rapidly becoming an important topic in the medical
community. The ability to automatically analyze any type of medical document could be the …

Risk factors for clozapine‐induced myocarditis and cardiomyopathy: A systematic review and meta‐analysis

M Vickers, V Ramineni, E Malacova… - Acta Psychiatrica …, 2022 - Wiley Online Library
Objective Clozapine is the most effective medication for treatment‐refractory schizophrenia,
but it is associated with severe cardiac adverse events including myocarditis and …

[PDF][PDF] Reflections on the complex history of the concept of clozapine-induced inflammation during titration

J de Leon - Psychiatria Danubina, 2022 - hrcak.srce.hr
REFLECTIONS ON THE COMPLEX HISTORY OF THE CONCEPT OF CLOZAPINE-INDUCED
INFLAMMATION DURING TITRATION Page 1 411 Psychiatria Danubina, 2022; Vol. 34, No. 3 …

A systematic review of clozapine‐associated inflammation and related monitoring

JG Leung, L Zhang, M Markota… - … : The Journal of …, 2023 - Wiley Online Library
Clozapine is an effective antipsychotic medication used for treatment‐resistant
schizophrenia. However, it is underutilized due to rigorous hematologic monitoring …

[HTML][HTML] Rational and translational implications of D-amino acids for treatment-resistant schizophrenia: from neurobiology to the clinics

A de Bartolomeis, L Vellucci, MC Austin, G De Simone… - Biomolecules, 2022 - mdpi.com
Schizophrenia has been conceptualized as a neurodevelopmental disorder with synaptic
alterations and aberrant cortical–subcortical connections. Antipsychotics are the mainstay of …

Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases

R de Filippis, JM Kane, N Kuzo, E Spina… - European …, 2022 - Elsevier
Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS)
syndrome is a rare adverse reaction. We aimed to screen a large pharmacovigilance …

Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia

M Qubad, RA Bittner - Therapeutic advances in …, 2023 - journals.sagepub.com
Despite its enduring relevance as the single most effective and important evidence-based
treatment for schizophrenia, underutilization of clozapine remains considerable. To a …

When, why and how to re-challenge Clozapine in Schizophrenia following myocarditis

M Qubad, G Dupont, M Hahn, SS Martin, V Puntmann… - CNS drugs, 2024 - Springer
Clozapine-induced myocarditis (CIM) is among the most important adverse events limiting
the use of clozapine as the most effective treatment for schizophrenia. CIM necessitates the …

High rates of myocarditis with clozapine in the Hunter region of Australia

S Tirupati, MK Arachchi - Schizophrenia research, 2024 - Elsevier
Objective To study the causes of clozapine treatment discontinuation and measure
clozapine-induced myocarditis (CIM) rates in an Australian region, to compare the observed …

Coronary artery disease in patients with severe mental illness

BT To, R Roy, N Melikian, FP Gaughran… - Interventional …, 2023 - pmc.ncbi.nlm.nih.gov
Severe mental illnesses (SMI), such as schizophrenia and bipolar disorder, are associated
with a decrease in life expectancy of up to two decades compared with the general …